Published Date: August, 2017
A recent report published by Infinium Global Research on hyaluronic acid market provides in depth analysis of segments and sub-segments in global as well as regional hyaluronic acid market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional hyaluronic acid market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global hyaluronic acid market. According to report the global hyaluronic acid market is projected to grow at a CAGR of 9.4% over the forecast period of 2017-2023.
Hyaluronic acid, also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. Its function in the body is to bind water and to lubricate movable parts of the body, such as joints and muscles. Its consistency and tissue-friendliness allows it to be beneficial in skin-care products as an excellent moisturizer. Because it is one of the most hydrophilic molecules in nature with numerous benefits for the human body it can be described as nature’s moisturizer. Hyaluronic acid helps to maintain normal joint cushioning. With these advantages, hyaluronic acid exhibits a wide range of applications in ophthalmology, dermatology, rheumatology, orthopedic surgery, otolaryngology, plastic surgery, drug delivery, and wound healing.
Figure 1: Global Hyaluronic Acid Market by Value 2015-2023
Rise in base of geriatric population, increasing incidence rates of osteoarthritis, ulcers and gingivitis, and rising demand for cosmetic procedures related to anti-aging process are some of the factors which are expected to expand the market significantly in the coming years. In addition, growing patient’s preference for minimally invasive surgical procedures, favorable reimbursement policies, and increasing awareness about health and beauty standards among the population are further driving this market in the coming years. Along with these factors, there are certain restraining factors that could hinder the market in future, which include availability of other cost effective treatment options. Introduction of newer technologies into the market and large number of product approvals witnessing the huge market growth.
The report on global hyaluronic acid market covers segments such as, type and application. On the basis of type the global hyaluronic acid market is categorized into single injection, three injections and five injections. On the basis of application the global hyaluronic acid market is categorized into osteoarthritis, ophthalmic, dermal fillers and vesicoureteral reflux.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015-2023.
Figure 2: Global Hyaluronic Acid Market by Region, CAGR % 2017-2023
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017-2023.
The report provides profiles of the companies in the global hyaluronic acid market such as, Allergan Inc, Sanofi, Genzyme Corporation, F.Hoffmann-La Roche Ltd., Zimmer Biomet, Smith & Nephew plc, Ferring Pharmaceuticals Inc., Anika Therapeutics Inc., Seikagaku and Salix Pharmaceuticals.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global hyaluronic acid market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of hyaluronic acid market. Moreover, the study highlights current market trends and provides forecast from 2017-2023. We also have highlighted future trends in the hyaluronic acid market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the hyaluronic acid market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Hyaluronic Acid Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Hyaluronic Acid Market
4. Global Hyaluronic Acid Market by Type
4.1. Single Injection
4.2. Three Injection
4.3. Five Injection
5. Global Hyaluronic Acid Market by Application
5.3. Dermal Fillers
5.4. Vesicoureteral Reflux
6. Global Hyaluronic Acid Market by Region 2017-2023
6.1. North America
6.1.1. North America Hyaluronic Acid Market by Type
6.1.2. North America Hyaluronic Acid Market by Application
6.1.3. North America Hyaluronic Acid Market by Country
6.2.1. Europe Hyaluronic Acid Market by Type
6.2.2. Europe Hyaluronic Acid Market by Application
6.2.3. Europe Hyaluronic Acid Market by Country
6.3.1. Asia-Pacific Hyaluronic Acid Market by Type
6.3.2. Asia-Pacific Hyaluronic Acid Market by Application
6.3.3. Asia-Pacific Hyaluronic Acid Market by Country
6.4.1. RoW Hyaluronic Acid Market by Type
6.4.2. RoW Hyaluronic Acid Market by Application
6.4.3. RoW Hyaluronic Acid Market by Sub-region
7. Company Covered
7.1. Allergan Inc
7.3. Genzyme Corporation
7.4. F.hoffmann-la Roche Ltd.
7.5. Zimmer Biomet
7.6. Smith & Nephew Plc
7.7. Ferring Pharmaceuticals Inc.
7.8. Anika Therapeutics Inc.
7.10. Salix Pharmaceuticals
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.